From Bench to Bedside
More universities are focusing efforts on technology transfer and industry partnerships to bring new therapies to market
Technology transfer, or the commercialization of scientific discoveries,...
Leaving the Bedside
Career opportunities for doctors extend far beyond the patient care setting.
When choosing to become a physician, most people expect to spend their entire working...
What Makes a Good Leader?
Health care leadership roles are often awarded to top clinicians and researchers, but experts say successful leaders need a different set of skills.
As cases...
Hematology and the Transgender Patient
An estimated 1.4 million U.S. adults (0.6% of all adults) self-report as transgender; yet, to date, little research has been conducted to understand cancer...
Who’s Watching the Watchdog?
With most drugs now approved through one of the FDA’s expedited-review pathways, is the agency approving drugs too quickly?
In recent years, the FDA has...
Gene Therapy for Hemophilia: Progress and Setbacks
As the FDA delayed the approval of the world’s first gene therapy for hemophilia A, companies forged ahead with phase III trials to gather...
New Rules of the Road in TTP Management
In July 2020, the International Society on Thrombosis and Haemostasis (ISTH) issued its first-ever guidelines for the treatment of thrombotic thrombocytopenic purpura (TTP), helping...
Racism Persists in Medicine, Including Hematology
Medicine is not exempt from the explicit and implicit racism seen in other parts of American life.
When Deirdra Terrell, PhD, MPH, started attending...
Rewriting the Rules of Blood Donation
What will the FDA’s newly loosened blood donation restrictions mean for donors, blood banks, and the safety of the national blood supply?
In the initial...
Questions and Controversies in Iron-Deficiency Anemia
Iron-deficiency is the most common nutritional deficiency in the world. It affects patients in both developed and developing countries and has been commonly recognized...